HSKA - Heska to Participate in the 41st J.P. Morgan Annual Healthcare Conference

PR Newswire

LOVELAND, Colo. , Dec. 23, 2022 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a leading global provider of advanced veterinary diagnostic and specialty solutions, announced that members of Heska's management team will participate in the upcoming 41 ^st Annual J.P. Morgan Healthcare Conference in San Francisco, CA.

Kevin Wilson , Heska's President & Chief Executive Officer, will present on Wednesday, January 11, 2023 at 9:45 a.m. Pacific Standard Time . A live audio webcast of Mr. Wilson's presentation will be available by visiting Heska J.P. Morgan 2023 Healthcare Conference Webcast . The webcast and presentation will be archived on the Company's website shortly after the event and a replay will be available for 90 days following the conference.

Mr. Wilson and members of Company management will also be participating in one-on-one meetings on January 11 ^th . To request a meeting, please contact J.P. Morgan at 1x1@jpmorgan.com or Heska Investor Relations at investorrelations@heska.com .

For more information regarding the J.P. Morgan 2023 Healthcare Conference, visit J.P. Morgan Healthcare Conference Website .

About Heska

Heska Corporation (NASDAQ: HSKA) manufactures, develops and sells advanced veterinary diagnostics, informatics, and specialty healthcare solutions through its two business segments: North America and International. Both segments include Point of Care Lab testing instruments and consumables, digital imaging products, software and services, data services, allergy testing and immunotherapy, and single-use offerings such as in-clinic diagnostic tests and heartworm preventive products. The North America segment also includes private label vaccine and pharmaceutical production for third-parties, primarily for herd animal health. For more information, please visit www.heska.com .

SOURCE Heska Corporation